NCT03193229View on ClinicalTrials.gov

MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

April 2, 2018

Study Completion Date

May 4, 2018

Conditions
Pre DiabetesObesity
Interventions
BEHAVIORAL

MapTrek

The objective of the study is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for or already diagnosed with pre-diabetes.

DEVICE

Fitbit

Fitbit

Trial Locations (1)

52241

Signal Center Innovation Lab, Coralville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Philip Polgreen

OTHER

NCT03193229 - MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes | Biotech Hunter | Biotech Hunter